CRISPR Therapeutics : CRSP

All CRISPR Therapeutics Articles

48 Articles

Trey Thoelcke | Feb 29, 2024 at 10:15 AM EST

CEO Dumps 20 Million Ginkgo Bioworks Shares

Why did Ginkgo Bioworks CEO Jason Kelly chop 20 million shares from his stake in the company? Is no turnaround…

Lee Jackson | May 31, 2023 at 8:54 AM EDT

Wednesday’s Top Analyst Upgrades and Downgrades: Abbott Labs, Boston Scientific, ChargePoint, Coinbase, Dollar General, Equitrans, Ford, Hasbro, Johnson & Johnson, Kenvue, Medtronic and More

Wednesday's top analyst upgrades and downgrades included Abbott Laboratories, Boston Scientific, ChargePoint, Coinbase Global, Dollar General, Equitrans Midstream, Ford, Hasbro,…

Lee Jackson | Apr 14, 2023 at 8:55 AM EDT

Friday’s Top Analyst Upgrades and Downgrades: American Airlines, Broadcom, Chevron, DraftKings, Exxon Mobil, Hertz, McDonald’s, Merck, Meta, Shopify and More

Friday's top analyst upgrades and downgrades included American Airlines, Broadcom, Chevron, DraftKings, Enphase Energy, EOG Resources, Exxon Mobil, First Solar,…

Chris Lange | Aug 10, 2022 at 10:51 AM EDT

Barclays Picks 2 Winners and 2 Losers After Earnings

Barclays recently issued a few calls across multiple industries picking a couple winners and a couple losers.

Chris Lange | Aug 9, 2022 at 10:55 AM EDT

Are Earnings Actually Priced In? Analysts Upgrade or Downgrade Nike, Palantir and More

Tuesday's additional top analyst upgrades and downgrades were on Bed Bath & Beyond, Clorox, CRISPR Therapeutics, LivePerson, Nike, Palantir Technologies,…

Chris Lange | Jun 24, 2022 at 10:23 AM EDT

Will CRISPR Stock Double in the Next Year?

One big Wall Street name thinks it has found a big winner in this gene-editing company, and the stock could…

Chris Lange | Jun 23, 2022 at 2:10 PM EDT

The Fed to the Rescue? Analysts Upgrade or Downgrade American Tower, Coinbase, Snowflake, Southwest and More

Thursday's additional top analyst upgrades and downgrades included American Tower, Coinbase, Snowflake, Southwest and more.

Lee Jackson | May 25, 2022 at 8:47 AM EDT

Wednesday’s Top Analyst Upgrades and Downgrades: eBay, EOG, Etsy, Global Payments, JPMorgan, MetLife, Otis, Salesforce, Wayfair and More

Wednesday's top analyst upgrades and downgrades included Albemarle, Camping World, eBay, EOG Resources, Etsy, Global Payments, IMAX, JPMorgan Chase, MetLife,…

Lee Jackson | May 12, 2022 at 8:52 AM EDT

Thursday’s Top Analyst Upgrades and Downgrades: Boeing, Capital One, Coinbase, Electronic Arts, Harley-Davidson, Peloton, Walmart, Wynn Resorts and More

Thursday's top analyst upgrades and downgrades included Alcon, Array Technologies, AZEK, Boeing, Capital One Financial, Coinbase Global, Corning, Electronic Arts,…

Lee Jackson | Feb 17, 2022 at 8:58 AM EST

Thursday’s Top Analyst Upgrades and Downgrades: Airbnb, Alcoa, Beyond Meat, Marriott, Monster Beverage, Paramount, Shopify, Toast, ZoomInfo and More

Thursday's top analyst upgrades and downgrades included Airbnb, Alcoa, Beyond Meat, Fidelity National Information Services, Marriott International, Monster Beverage, Paramount…

Lee Jackson | Jan 4, 2022 at 7:15 AM EST

5 Sizzling ‘Strong Buy’ Analyst Biotechnology Picks for 2022

Biotechnology was a huge laggard last year, but Truist Securities is out with its five top picks for 2022 that…

Chris Lange | Dec 30, 2021 at 10:21 AM EST

Cathie Wood’s ARK Invest Buys Nearly 60,000 Shares of CRISPR

A couple of Cathie Wood's ARK Invest exchange-traded funds bought nearly 60,000 shares of CRISPR Therapeutics on December 29 for…

Chris Lange | Dec 7, 2021 at 11:45 AM EST

Tuesday Afternoon’s Analyst Upgrades and Downgrades: Alibaba, Apple, Canopy Growth, Tesla and More

Tuesday afternoon's top analyst upgrades and downgrades included Alibaba, Apple, AstraZeneca, Canopy Growth, CNX Resources, Murphy Oil, Ross Stores and…

Chris Lange | Oct 19, 2021 at 3:18 PM EDT

Tuesday Afternoon Analyst Upgrades and Downgrades: CRISPR, Editas, Esperion Therapeutics, Marriott Penn National Gaming and More

Tuesday afternoon's analyst upgrades and downgrades included CRISPR, Editas, Esperion Therapeutics, Marriott Penn National Gaming and more.

Chris Lange | Oct 14, 2021 at 9:41 AM EDT

Cathie Wood’s ARK Invest Buys Over 675,000 More Shares of CRISPR

A couple of Cathie Wood's ARK Invest exchange-traded funds bought over 675,000 shares of CRISPR Therapeutics on October 14.

1 2 3 4

CRISPR Therapeutics : CRSP

All CRISPR Therapeutics Articles

CEO Dumps 20 Million Ginkgo Bioworks Shares

Wednesday’s Top Analyst Upgrades and Downgrades: Abbott Labs, Boston Scientific, ChargePoint, Coinbase, Dollar General, Equitrans, Ford, Hasbro, Johnson & Johnson, Kenvue, Medtronic and More

Friday’s Top Analyst Upgrades and Downgrades: American Airlines, Broadcom, Chevron, DraftKings, Exxon Mobil, Hertz, McDonald’s, Merck, Meta, Shopify and More

Barclays Picks 2 Winners and 2 Losers After Earnings

Are Earnings Actually Priced In? Analysts Upgrade or Downgrade Nike, Palantir and More

Will CRISPR Stock Double in the Next Year?

The Fed to the Rescue? Analysts Upgrade or Downgrade American Tower, Coinbase, Snowflake, Southwest and More

Wednesday’s Top Analyst Upgrades and Downgrades: eBay, EOG, Etsy, Global Payments, JPMorgan, MetLife, Otis, Salesforce, Wayfair and More

Thursday’s Top Analyst Upgrades and Downgrades: Boeing, Capital One, Coinbase, Electronic Arts, Harley-Davidson, Peloton, Walmart, Wynn Resorts and More

Thursday’s Top Analyst Upgrades and Downgrades: Airbnb, Alcoa, Beyond Meat, Marriott, Monster Beverage, Paramount, Shopify, Toast, ZoomInfo and More

5 Sizzling ‘Strong Buy’ Analyst Biotechnology Picks for 2022

Cathie Wood’s ARK Invest Buys Nearly 60,000 Shares of CRISPR

Tuesday Afternoon’s Analyst Upgrades and Downgrades: Alibaba, Apple, Canopy Growth, Tesla and More

Tuesday Afternoon Analyst Upgrades and Downgrades: CRISPR, Editas, Esperion Therapeutics, Marriott Penn National Gaming and More

Cathie Wood’s ARK Invest Buys Over 675,000 More Shares of CRISPR

This High-Yield ETF Combines Bond Investing With Emerging Market Currencies

SoFi Stock Could Jump 26% as Market Overreacts to One Soft Segment

China’s Semiconductor Equipment Companies Gain Share Despite U.S. Sanctions

52% of Americans Are Building Wealth While Ignoring Their Greatest Risk

3 Reasons Retirees Should Not Enroll in Medicare Advantage for 2026

This High-Yield ETF Combines Bond Investing With Emerging Market Currencies

SoFi Stock Could Jump 26% as Market Overreacts to One Soft Segment

CRISPR Therapeutics : CRSP

All CRISPR Therapeutics Articles

CEO Dumps 20 Million Ginkgo Bioworks Shares

Wednesday’s Top Analyst Upgrades and Downgrades: Abbott Labs, Boston Scientific, ChargePoint, Coinbase, Dollar General, Equitrans, Ford, Hasbro, Johnson & Johnson, Kenvue, Medtronic and More

Friday’s Top Analyst Upgrades and Downgrades: American Airlines, Broadcom, Chevron, DraftKings, Exxon Mobil, Hertz, McDonald’s, Merck, Meta, Shopify and More

Barclays Picks 2 Winners and 2 Losers After Earnings

Are Earnings Actually Priced In? Analysts Upgrade or Downgrade Nike, Palantir and More

Will CRISPR Stock Double in the Next Year?

The Fed to the Rescue? Analysts Upgrade or Downgrade American Tower, Coinbase, Snowflake, Southwest and More

Wednesday’s Top Analyst Upgrades and Downgrades: eBay, EOG, Etsy, Global Payments, JPMorgan, MetLife, Otis, Salesforce, Wayfair and More

Thursday’s Top Analyst Upgrades and Downgrades: Boeing, Capital One, Coinbase, Electronic Arts, Harley-Davidson, Peloton, Walmart, Wynn Resorts and More

Thursday’s Top Analyst Upgrades and Downgrades: Airbnb, Alcoa, Beyond Meat, Marriott, Monster Beverage, Paramount, Shopify, Toast, ZoomInfo and More

5 Sizzling ‘Strong Buy’ Analyst Biotechnology Picks for 2022

Cathie Wood’s ARK Invest Buys Nearly 60,000 Shares of CRISPR

Tuesday Afternoon’s Analyst Upgrades and Downgrades: Alibaba, Apple, Canopy Growth, Tesla and More

Tuesday Afternoon Analyst Upgrades and Downgrades: CRISPR, Editas, Esperion Therapeutics, Marriott Penn National Gaming and More

Cathie Wood’s ARK Invest Buys Over 675,000 More Shares of CRISPR

This High-Yield ETF Combines Bond Investing With Emerging Market Currencies

SoFi Stock Could Jump 26% as Market Overreacts to One Soft Segment

China’s Semiconductor Equipment Companies Gain Share Despite U.S. Sanctions

Featured Reads

52% of Americans Are Building Wealth While Ignoring Their Greatest Risk

3 Reasons Retirees Should Not Enroll in Medicare Advantage for 2026